Bayer CropScience Limited (BOM:506285)
4,834.95
+67.75 (1.42%)
At close: Feb 12, 2026
Bayer CropScience Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 56,206 | 54,734 | 51,062 | 51,397 | 47,344 | 42,613 |
| 56,206 | 54,734 | 51,062 | 51,397 | 47,344 | 42,613 | |
Revenue Growth (YoY) | 7.73% | 7.19% | -0.65% | 8.56% | 11.10% | 18.06% |
Cost of Revenue | 34,001 | 34,142 | 29,256 | 28,305 | 26,771 | 24,619 |
Gross Profit | 22,205 | 20,592 | 21,806 | 23,092 | 20,573 | 17,994 |
Selling, General & Admin | 7,462 | 7,527 | 6,902 | 8,616 | 7,836 | 5,726 |
Other Operating Expenses | 6,307 | 6,149 | 5,117 | 5,211 | 4,589 | 4,148 |
Operating Expenses | 14,676 | 14,525 | 12,759 | 14,622 | 13,070 | 10,609 |
Operating Income | 7,529 | 6,067 | 9,047 | 8,470 | 7,503 | 7,385 |
Interest Expense | -200 | -170 | -196 | -223 | -118 | -110 |
Interest & Investment Income | 566 | 566 | 484 | 340 | 245 | 314 |
Currency Exchange Gain (Loss) | -2 | -2 | -2 | -22 | -2 | -15 |
Other Non Operating Income (Expenses) | -176 | 166 | 148 | 159 | 184 | 157 |
EBT Excluding Unusual Items | 7,717 | 6,627 | 9,481 | 8,724 | 7,812 | 7,731 |
Merger & Restructuring Charges | - | - | - | - | - | 51 |
Gain (Loss) on Sale of Investments | 191 | 191 | 148 | 135 | 94 | 103 |
Gain (Loss) on Sale of Assets | 256 | 256 | -24 | 1,043 | 579 | 64 |
Asset Writedown | - | - | -191 | -1 | -17 | -4 |
Pretax Income | 8,164 | 7,074 | 9,414 | 9,901 | 8,468 | 7,945 |
Income Tax Expense | 1,460 | 1,394 | 2,009 | 2,319 | 2,015 | 3,014 |
Net Income | 6,704 | 5,680 | 7,405 | 7,582 | 6,453 | 4,931 |
Net Income to Common | 6,704 | 5,680 | 7,405 | 7,582 | 6,453 | 4,931 |
Net Income Growth | 28.75% | -23.29% | -2.33% | 17.50% | 30.87% | 3.92% |
Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 | 45 |
Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 | 45 |
Shares Change (YoY) | 0.00% | - | - | - | - | - |
EPS (Basic) | 149.16 | 126.38 | 164.77 | 168.71 | 143.58 | 109.72 |
EPS (Diluted) | 149.16 | 126.38 | 164.77 | 168.71 | 143.58 | 109.72 |
EPS Growth | 28.75% | -23.29% | -2.33% | 17.50% | 30.87% | 3.92% |
Free Cash Flow | - | 2,211 | 9,059 | 5,320 | 1,601 | 6,447 |
Free Cash Flow Per Share | - | 49.20 | 201.57 | 118.38 | 35.62 | 143.45 |
Dividend Per Share | 125.000 | 125.000 | 140.000 | 130.000 | 25.000 | 115.000 |
Dividend Growth | - | -10.71% | 7.69% | 420.00% | -78.26% | 360.00% |
Gross Margin | 39.51% | 37.62% | 42.70% | 44.93% | 43.45% | 42.23% |
Operating Margin | 13.40% | 11.09% | 17.72% | 16.48% | 15.85% | 17.33% |
Profit Margin | 11.93% | 10.38% | 14.50% | 14.75% | 13.63% | 11.57% |
Free Cash Flow Margin | - | 4.04% | 17.74% | 10.35% | 3.38% | 15.13% |
EBITDA | 7,872 | 6,429 | 9,434 | 8,861 | 7,901 | 7,799 |
EBITDA Margin | 14.01% | 11.75% | 18.48% | 17.24% | 16.69% | 18.30% |
D&A For EBITDA | 343.25 | 362 | 387 | 391 | 398 | 414 |
EBIT | 7,529 | 6,067 | 9,047 | 8,470 | 7,503 | 7,385 |
EBIT Margin | 13.40% | 11.09% | 17.72% | 16.48% | 15.85% | 17.33% |
Effective Tax Rate | 17.88% | 19.71% | 21.34% | 23.42% | 23.79% | 37.94% |
Revenue as Reported | 57,061 | 55,931 | 51,842 | 52,036 | 47,890 | 43,251 |
Advertising Expenses | - | 2,927 | 2,412 | 3,153 | 3,080 | 1,991 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.